Spravato Now Approved Patient and HCP Websites Mar 26, 2019Mar 27, 2019 Brand: Spravato (esketamine), Nasal Spray Parent Company: Janssen Drug Type: Boxed Warning Drug Category: Central Nervous System Campaign: now-approved Targeting: HCPs, Patients, Caregivers Patient Website: https://www.spravato.com/ HCP Website: https://www.spravatohcp.com/ Patient “Now Approved” Page HCP: Homepage HCP: About HCP: Efficacy HCP: How Studied HCP: Administration HCP: Mobile Safety HCP Homepage (Mobile) HCP: Mobile Nav